Wikipedia -WSS

Wikipedia

author：focus 2025-09-27 16:47:35 - browse：8

Christopher Viehbacher on stage at the 2023 STAT Summit. — Biogen CEO Christopher Viehbacher STAT

Two years after a big scientific swing nearly pushed Biogen to the brink, CEO Christopher Viehbacher is embarking on a corporate rethink, one that balances Biogen’s characteristic risky bets with a frank commitment to pragmatism.

Speaking at the STAT Summit in Boston on Thursday, Viehbacher said his Biogen predecessors fell off track through a few unsound investments and an all-or-nothing bet on Aduhelm, the Alzheimer’s disease treatment that became a pharmaceutical cautionary tale. Viehbacher, one year into his tenure at the storied company, said Biogen’s future will rely on taking a more disciplined approach to risk.

“There’s a huge amount of pride inside the company that we go after problems other people don’t,” Viehbacher said, “but at the end of the day you also have to get medicines through the pipeline to benefit patients, and that’s why we’re expanding the aperture of what we’re doing in R&D.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Senate panel puts off hardest PBM reforms for another day

WSS

Medicare Advantage enrollment grows 7.1% to 33.4 million people

MD Anderson's Padmanee Sharma responds to research credit suit

UHS says company favors patients whose insurance pays more

Measles policy set amid Florida outbreak alarms vaccine proponents

Abridge raises $150m as clinical notes automation market heats up

STAT Report: Patient voices and perspectives

Wikipedia

Wikipedia

focus

Activists slam private health insurers over coverage restrictions

As AI regulations shape up, health tech startups beg for clarity

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare Advantage enrollment grows 7.1% to 33.4 million people

In Memoriam: Notable people who died in 2023

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Medical records are filled with copy

Truvian presents data for its desktop blood

Guidelines to prevent youth baseball injuries need more muscle

STAT Report: Patient voices and perspectives

focus

Dems pitch expanding Medicare power to negotiate drug prices

A new crop of companies is reshaping the health data economy

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Biden warns of ‘dark winter’ during final presidental debate

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

New study raises questions about niacin and heart health

leisure time

knowledge

knowledge

knowledge